Skip to content
Screener

Emergent Biosolutions EBS Gain (loss) on extinguishment of debt

Gain (loss) on extinguishment of debt at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$0
Medline, Inc. logo
Medline, Inc.MDLN
-$14.5M-81.3%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
-$18M

Other financials

Income statement

See full
Revenue$234.3M+66.3%
Gross profit$137.2M+85.4%
Operating income-$125.1M-7,919%
Net income-$180.2M-1,402%
EPS (diluted)-$3.49-1,486%

Balance sheet

See full
Cash & equivalents$140.9M-48.0%
Total debt$588.2M-13.0%
Total equity$341.4M-36.3%
Total assets$1.1B-21.2%

Cash flow

See full
Operating cash flow$56.1M-47.3%
CapEx$2.1M-27.6%
Free cash flow$54.0M-47.8%

Valuation

See full
Market cap$272.26M-16.8%
Enterprise value$719.56M-1.8%
P/S0.4×0.0×

Profitability

See full
Gross margin55.9%+2.4pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin11.9%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.7×+0.5×
Current ratio5.4×-0.2×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.

The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.

Filed
Aug 5, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001367644-26-000082
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other income (expense):
Interest expense(10.0)(14.7)(21.0)(29.4)
Loss on assets held-for-sale(10.7)(10.7)(12.2)
Loss on debt extinguishment(20.5)(20.5)
Other, net(3.7)13.966.0
Total other income (expense), net(41.2)(18.4)(38.3)24.4
Income (loss) before income taxes(166.3)(16.8)(152.9)75.9
Income tax provision (benefit)13.9(4.8)20.519.9

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Emergent Biosolutions's gain (loss) on extinguishment of debt?
Emergent Biosolutions (EBS) reported gain (loss) on extinguishment of debt of -$20.5M in Q2 2026.
What does gain (loss) on extinguishment of debt mean?
Gains or losses from retiring debt before maturity — gains when debt is repurchased below par, losses when premiums are paid for early redemption.

Ask your AI about Emergent Biosolutions's gain (loss) on extinguishment of debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude